Steven Romano
Chief Tech/Sci/R&D Officer bei SILENCE THERAPEUTICS PLC
Vermögen: 11 434 $ am 31.07.2023
Profil
Steven Joseph Romano is currently the Chairman at the National Pharmaceutical Council.
He is also a Director at Evolution Research Group LLC and the Head of Research & Development at Silence Therapeutics Plc.
Previously, he held the position of Senior VP & Head of Global Medicines Development at Pfizer Inc. from 1999 to 2015.
He then served as the Chief Scientific Officer & Executive VP at Mallinckrodt Plc from 2015 to 2022.
Additionally, he has worked as the Chief Scientific Officer & Executive VP at Mallinckrodt Pharmaceuticals Ltd.
Dr. Romano completed his undergraduate studies at Washington University in St. Louis and obtained a doctorate degree from the University of Missouri School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SILENCE THERAPEUTICS PLC
0,01% | 01.03.2024 | 12 993 ( 0,01% ) | 11 434 $ | 31.07.2023 |
Aktive Positionen von Steven Romano
| Unternehmen | Position | Beginn |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01.04.2023 |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Chairman | 04.11.2021 |
Evolution Research Group LLC
 Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Evolution Research Group LLC provides in-patient and out-patient clinical trial services to pharmaceutical companies. It specializes in psychiatric and neurological disorders, sleep disorders, addictions, acute and chronic pain, renal insufficiency and hepatic impairment, and normal healthy volunteers. The company was founded in 2014 and is headquartered in New Providence, NJ. | Director/Board Member | - |
Ehemalige bekannte Positionen von Steven Romano
| Unternehmen | Position | Ende |
|---|---|---|
| MALLINCKRODT PLC | Chief Tech/Sci/R&D Officer | 31.12.2022 |
| PFIZER, INC. | Corporate Officer/Principal | 01.05.2015 |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Staines Upon Thames, UK and was founded in 2015. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Steven Romano
| Washington University in St. Louis | Undergraduate Degree |
| University of Missouri School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Private Unternehmen | 3 |
|---|---|
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Commercial Services |
Evolution Research Group LLC
Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Evolution Research Group LLC provides in-patient and out-patient clinical trial services to pharmaceutical companies. It specializes in psychiatric and neurological disorders, sleep disorders, addictions, acute and chronic pain, renal insufficiency and hepatic impairment, and normal healthy volunteers. The company was founded in 2014 and is headquartered in New Providence, NJ. | Commercial Services |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Staines Upon Thames, UK and was founded in 2015. | Health Technology |
